Study guide

12.3 Early-Onset & Late-Onset Neonatal Sepsis, GBS & TORCH Infections

RNC-MNN Maternal Newborn Nursing Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 RNC-MNN Credential Overview, Eligibility & Exam Format 1.2 Evidence-Based Nursing Practice, Legal-Ethical Standards & Study Strategies

2 Chapter 1: Pregnancy & Intrapartum Risk Factors

2.1 Pre-existing Maternal Conditions, Gestational Complications & High-Risk Antepartum Factors 2.2 Intrapartum Complications: Labor Abnormalities, Rupture of Membranes & Chorioamnionitis 2.3 Operative Delivery, Anesthesia Effects & Perinatal Trauma

3 Chapter 2: Maternal Postpartum Physical Assessment & Recovery

3.1 Uterine Involution, Fundal Assessment & Lochial Progression 3.2 Perineal Healing, Episiotomy, Lacerations & Cesarean Wound Evaluation 3.3 Cardiopulmonary, Renal, Gastrointestinal & Musculoskeletal Adaptations

4 Chapter 3: Maternal Nursing Care, Psychosocial Health & Education

4.1 Multimodal Pain Management, Early Ambulation & Bladder/Bowel Recovery 4.2 Psychosocial Transition: Rubin's Phases, Family Bonding & Perinatal Mood Screening 4.3 Patient Education, Contraception, Immunizations & POST-BIRTH Warning Signs

5 Chapter 4: Lactation & Infant Feeding

5.1 Breast Anatomy, Lactogenesis & Endocrine Regulation 5.2 Latch Mechanics, Milk Transfer Assessment (LATCH Score) & Feeding Frequency 5.3 Nipple Trauma, Engorgement, Ankyloglossia & Safe Formula Feeding

6 Chapter 5: Normal Newborn Transition & Assessment

6.1 Cardiopulmonary Transition, Thermal Balance & Cold Stress Prevention 6.2 Systematic Head-to-Toe Examination & Normal Physiologic Variations 6.3 Gestational Age Assessment (New Ballard Score) & Primitive Reflexes

7 Chapter 6: Routine Newborn Care, Resuscitation & Screening

7.1 Immediate Post-Birth Care, Vitamin K, Eye Prophylaxis & Umbilical Cord Care 7.2 Universal Screenings: CCHD, Universal Hearing Screen & Metabolic Bloodspots 7.3 Neonatal Resuscitation Program (NRP) 9th Edition Core Algorithm 7.4 AAP Safe Sleep Guidelines, SUID Prevention & Parent Guidance

8 Chapter 7: Postpartum Hemorrhage & Hematologic Disorders

8.1 Postpartum Hemorrhage: Definitions, Risk Factors & The 4 Ts 8.2 Quantitative Blood Loss (QBL), PPH Staging & Pharmacologic/Surgical Protocols 8.3 Postpartum Coagulopathies (DIC, ITP) & Venous Thromboembolism (DVT, PE)

9 Chapter 8: Postpartum Infections, Hypertension & Cardiopulmonary Emergencies

9.1 Preeclampsia, Eclampsia & HELLP Syndrome in the Postpartum Period 9.2 Endometritis, Surgical Site Infections, UTI & Mastitis 9.3 Maternal Sepsis: Recognition, Resuscitation & Source Control 9.4 Postpartum Cardiopulmonary & Neurologic Emergencies

10 Chapter 9: Endocrine, Psychiatric & Substance Use Complications

10.1 Gestational & Pre-existing Diabetes Postpartum & Postpartum Thyroiditis 10.2 Postpartum Depression, Anxiety Disorders & Postpartum Psychosis 10.3 Perinatal Substance Use, Opioid Use Disorder, Withdrawal & Harm Reduction

11 Chapter 10: Newborn Respiratory & Cardiovascular Complications

11.1 Transient Tachypnea (TTN), Respiratory Distress Syndrome (RDS) & Meconium Aspiration (MAS) 11.2 Congenital Heart Defects (Cyanotic vs. Acyanotic) & Postpartum Presentation 11.3 Persistent Pulmonary Hypertension of the Newborn (PPHN) & Apnea/Bradycardia

12 Chapter 11: Newborn Metabolic, Neurologic, Gastrointestinal & Infectious Complications

12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders 12.2 Neonatal Hyperbilirubinemia & Hematologic Complications 12.3 Early-Onset & Late-Onset Neonatal Sepsis, GBS & TORCH Infections 12.4 Neonatal Abstinence Syndrome (NAS/NOWS) & Birth Trauma/Injuries 12.5 Neonatal Neurologic & Gastrointestinal Complications

12.3 Early-Onset & Late-Onset Neonatal Sepsis, GBS & TORCH Infections

Key Takeaways Explain This Topic AI

Temperature instability, respiratory change, poor feeding, lethargy, apnea, perfusion change, or glucose instability can be neonatal sepsis; deterioration matters more than fever alone.

Obtain an adequate-volume blood culture before antibiotics when feasible, but do not delay empiric treatment of a symptomatic or unstable infant.

CBC indices, I:T ratio, CRP, and procalcitonin cannot diagnose or exclude sepsis alone; interpret trends with culture and clinical condition.

Well-appearing infants with perinatal risk are managed using a validated categorical pathway, multivariate EOS calculator, or structured serial examinations—not one universal observation rule.

Congenital CMV, toxoplasmosis, rubella, syphilis, and HSV overlap clinically; obtain pathogen-specific testing and treatment promptly.

Last updated: September 2026

12.3 Neonatal Sepsis & Congenital Infections

Core Focus: Neonates often deteriorate without fever or a dramatic laboratory abnormality. Recognize subtle change, obtain reliable cultures, start time-sensitive therapy in symptomatic infants, and use a validated risk pathway for well infants.

Early- and late-onset sepsis

Early-onset disease usually reflects vertical exposure; Group B Streptococcus and E. coli are major pathogens. Risks include suspected intraamniotic infection, prolonged rupture, prematurity, and inadequate indicated intrapartum prophylaxis. Late-onset disease reflects community or healthcare exposure and includes staphylococci and resistant gram-negative organisms depending on setting.

Warning signs include temperature instability, apnea, grunting/tachypnea, increasing oxygen need, poor feeding, vomiting/distention, lethargy or irritability, hypotonia, glucose instability, jaundice, pallor/mottling, delayed capillary refill, tachycardia or bradycardia, seizure, or bulging fontanelle. No single sign is required.

Evaluation and treatment

For a symptomatic infant, stabilize airway/breathing/circulation and glucose, obtain an adequate blood culture (commonly at least 1 mL) and indicated labs, and give empiric IV antibiotics promptly. Lumbar puncture is performed when meningitis is suspected or culture/clinical course indicates, when the infant is stable enough. Chest, urine, placental, or other studies depend on age and source.

Ampicillin plus an aminoglycoside is common initial early-onset coverage; late-onset choices follow local flora, resistance, devices, and meningitis risk. Verify neonatal dose and interval by gestational/postnatal age, weight, renal function, and drug levels. Narrow or stop antibiotics based on culture, clinical course, and stewardship protocol.

A CBC is neither sensitive nor specific. Leukopenia, neutropenia, thrombocytopenia, or a high immature-to-total neutrophil ratio can support concern, but the I:T ratio is not a stand-alone diagnostic threshold. CRP rises late; serial low values can support stopping therapy in a well infant but do not justify withholding initial treatment from an ill infant.

Well-appearing infant with EOS risk

Facilities use one of three AAP-supported approaches for infants at least 35 weeks: categorical risk assessment, a multivariate early-onset sepsis calculator, or structured serial physical examinations. Maternal fever/intraamniotic infection, gestational age, duration of membrane rupture, GBS status, antibiotic agent and timing, and the infant's evolving examination all matter. “Less than four hours of penicillin” is not by itself a mandate for NICU admission, laboratory testing, antibiotics, or one universal 36–48-hour stay. Follow the selected institutional pathway and reassess promptly if symptoms develop.

Major congenital infections

Infection High-yield clues Evaluation/treatment principles

CMV Growth restriction, petechiae, hepatosplenomegaly, microcephaly, periventricular calcifications, hearing loss Confirm with saliva/urine PCR in the congenital window; assess hearing, eyes, CNS, blood/liver; antiviral therapy for qualifying symptomatic disease

Toxoplasmosis Chorioretinitis, hydrocephalus, diffuse intracranial calcifications Maternal/infant serology and PCR; prolonged specialist-directed antiparasitic therapy

Rubella Cataracts, hearing loss, PDA/pulmonary artery stenosis, “blueberry muffin” lesions Confirm virologically; supportive specialty care and infection-control follow-up

Syphilis Rhinitis, rash including palms/soles, hepatosplenomegaly, anemia/thrombocytopenia, bone disease; may be asymptomatic Compare maternal treatment/serology and infant exam/titer; penicillin regimen depends on evaluation and follow-up certainty

HSV Vesicles may be absent; sepsis-like shock, hepatitis, encephalitis, seizure, eye/skin/mouth disease Obtain surface/blood/CSF testing as indicated and begin IV acyclovir promptly when suspected

Congenital infection can be present despite a well appearance at birth. Ensure definitive hearing, vision, neurodevelopmental, laboratory, and specialty follow-up appropriate to the pathogen.

Medication safety, infection control, and follow-up

Before administering antibiotics or acyclovir, verify weight, gestational and postnatal age, renal function, dose interval, vascular access, culture time, and compatibility. Monitor urine output and creatinine with aminoglycosides and follow level-monitoring policy. Acyclovir requires adequate hydration and renal surveillance. Ceftriaxone is generally avoided in neonates at risk for bilirubin displacement and in those receiving calcium-containing IV solutions; select the institution's neonatal cephalosporin alternative when one is needed.

Use standard precautions for all infants and add pathogen-specific isolation. Vesicular HSV lesions, draining congenital-syphilis lesions/secretions, rubella, and some CMV exposures require distinct precautions and staff counseling. Hand hygiene and central-line care prevent late-onset infection; do not separate a stable dyad reflexively when precautions and treatment can be delivered safely.

At discharge after infection or congenital-infection evaluation, identify who reviews every pending culture/PCR and how the family will be reached. Arrange hearing, eye, neurologic, developmental, liver/hematologic, and infectious-disease follow-up appropriate to the pathogen. Teach caregivers to seek urgent care for fever or hypothermia, breathing change, poor feeding, fewer wet diapers, unusual sleepiness, color change, or seizure.

Because maternal and infant records may separate after discharge, reconcile the maternal infection, GBS prophylaxis, rupture duration, cultures, placental findings, and neonatal medications in the handoff. State exactly what remains pending and the contingency for a positive result. This closed-loop transfer is especially important when the infant leaves before the maternal culture is final.

Loading diagram... Neonatal Sepsis Evaluation & TORCH Pathogen Differential Flowchart